Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Platform Team

The Lipidomics platform, part of the COI - Mass Spectrometry Laboratory at NDM, allows the identification and quantification of targeted lipids in physiological samples, including cells, media, serum/plasma, and tissue. For the moment we have been working on inflammatory lipids (eicosanoids and relevant fatty acids) and steroids, but this workflow can be implemented for other lipid families.

Instrumentation:  Agilent Technologies 6495 Triple Quad LC/MS.

Our latest publication: "Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Lukaemia" by Scott H. et al., Full access to the atricle in the following link: https://www.mdpi.com/1422-0067/24/21/15513